{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+pharmacotherapeutic+protocol&page=2", "query": { "intervention": "Standard pharmacotherapeutic protocol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 216, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+pharmacotherapeutic+protocol&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+pharmacotherapeutic+protocol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T06:12:36.940Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04469530", "title": "Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "Sirolimus", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 55, "start_date": "2020-09-16", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 5, "location_summary": "Atlanta, Georgia • St Louis, Missouri • Pittsburgh, Pennsylvania + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04469530" }, { "nct_id": "NCT02938377", "title": "Alcohol Research Consortium in HIV-Intervention Research Arm", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV Positive", "Alcohol Use" ], "interventions": [ { "name": "Computerized Brief Intervention (CBI)", "type": "BEHAVIORAL" }, { "name": "CBT4CBT", "type": "BEHAVIORAL" }, { "name": "Recommendation and Counseling for Alcohol Pharmacotherapy", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4985, "start_date": "2017-11-06", "completion_date": "2023-11-01", "has_results": true, "last_update_posted_date": "2025-03-10", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 2, "location_summary": "Birmingham, Alabama • Seattle, Washington", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02938377" }, { "nct_id": "NCT04694846", "title": "Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Non-Small Cell Carcinoma", "Head and Neck Squamous Cell Carcinoma" ], "interventions": [ { "name": "Nicotine Replacement", "type": "DRUG" }, { "name": "Bupropion Hydrochloride Controlled-release", "type": "DRUG" }, { "name": "Varenicline", "type": "DRUG" }, { "name": "Tobacco Cessation Counseling", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Quality of Life Assessment", "type": "OTHER" }, { "name": "Best Practice", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2020-08-19", "completion_date": "2024-08-16", "has_results": false, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04694846" }, { "nct_id": "NCT03054896", "title": "A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Richter Syndrome" ], "interventions": [ { "name": "Venetoclax", "type": "DRUG" }, { "name": "DA-EPOCH-R", "type": "OTHER" }, { "name": "R-CHOP", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2017-03-08", "completion_date": "2027-12-01", "has_results": true, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Columbus, Ohio • Houston, Texas", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03054896" }, { "nct_id": "NCT03858712", "title": "EHR-embedded OCDT in Breast or GI Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Oral Cancer Directed Therapy", "Breast Cancer", "Gastrointestinal Cancer", "Oral Chemotherapy" ], "interventions": [ { "name": "Active Care Team Alert", "type": "OTHER" }, { "name": "Passive Care Team Alert", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2019-03-13", "completion_date": "2021-11-23", "has_results": false, "last_update_posted_date": "2022-05-12", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03858712" }, { "nct_id": "NCT07504458", "title": "Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Promyelocytic Leukemia (APL)", "Acute Promyelocytic Leukaemia", "Acute Promyelocytic Leukemia With PML-RARA", "Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA", "Acute Promyelocytic Leukemia" ], "interventions": [ { "name": "QTX-2101 + ATRA", "type": "DRUG" }, { "name": "IV arsenic trioxide (ATO) + ATRA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Quetzal Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "71 Years", "sex": "ALL", "summary": "18 Years to 71 Years" }, "enrollment_count": 150, "start_date": "2026-06-08", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Duarte, California • Los Angeles, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07504458" }, { "nct_id": "NCT01783535", "title": "Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Retinoblastoma" ], "interventions": [ { "name": "vincristine", "type": "DRUG" }, { "name": "topotecan", "type": "DRUG" }, { "name": "filgrastim", "type": "DRUG" }, { "name": "PEG-filgrastim", "type": "DRUG" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "focal therapy", "type": "OTHER" }, { "name": "etoposide", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "MESNA", "type": "DRUG" }, { "name": "doxorubicin", "type": "DRUG" }, { "name": "enucleation", "type": "PROCEDURE" }, { "name": "external beam radiation or proton beam radiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE", "RADIATION" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 174, "start_date": "2013-06-19", "completion_date": "2027-02-21", "has_results": true, "last_update_posted_date": "2026-06-29", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01783535" }, { "nct_id": "NCT00277043", "title": "A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Supportive", "Ill-defined Sites" ], "interventions": [ { "name": "paclitaxel, docetaxel, taxane", "type": "DRUG" }, { "name": "taxane", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New Mexico Cancer Research Alliance", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2002-06", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2011-09-27", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277043" }, { "nct_id": "NCT00416624", "title": "Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia", "Leukemia", "Lymphoma", "Lymphoproliferative Disorder", "Multiple Myeloma and Plasma Cell Neoplasm", "Precancerous Condition", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "darbepoetin alfa", "type": "DRUG" }, { "name": "epoetin alfa", "type": "DRUG" }, { "name": "fatigue assessment and management", "type": "PROCEDURE" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 239, "start_date": "2007-05", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2017-02-10", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00416624" }, { "nct_id": "NCT01392287", "title": "Treatment Resistant Geriatric Depression in Primary Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Memantine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mclean Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "55 Years to 89 Years" }, "enrollment_count": 12, "start_date": "2010-05", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2017-02-01", "last_synced_at": "2026-09-30T06:12:36.940Z", "location_count": 1, "location_summary": "Belmont, Massachusetts", "locations": [ { "city": "Belmont", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01392287" } ] }